MESOTHELIOMA V/S ADENOCARCINOMA OF LUNG DO SERUM MARKERS HELP?
2008
Serum Markers in Lung Cancer Diagnosis
publication
Evidence: moderate
Author Information
Author(s): Neeraj Gupta
Primary Institution: JLN Medical College
Hypothesis
Can serum markers help differentiate between malignant mesothelioma and adenocarcinoma of the lung?
Conclusion
Serum SMR levels may help distinguish between mesothelioma and lung adenocarcinoma, with higher levels indicating mesothelioma.
Supporting Evidence
- Raised serum SMR concentration is indicative of mesotheliomas with sensitivity of 84% and specificity of 100%.
- None of the seven patients with lung adenocarcinoma had raised SMR concentrations.
- Higher SMR levels in asbestos exposed individuals might predict disease development.
Takeaway
Doctors can use a blood test to check for a marker that helps tell if a patient has a type of lung cancer called mesothelioma instead of another type called adenocarcinoma.
Methodology
The study discusses the use of serum markers, particularly SMR, in diagnosing mesothelioma compared to adenocarcinoma.
Limitations
The specificity of SMR may fall below 100% due to other cancers causing increased levels.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website